About me

Research focus:

Our group wants to understand the molecular consequences of SVs in development and disease. One powerful technique that we use in the lab to answer this question is synthetic genomics. This technique allows us to better understand human pathologies and develop novel therapies by faithfully recapitulating human diseases in mice.

Joined LMS:

2024

About me:

I first got very enthusiastic about understanding the basic mechanisms of genetic diseases when I was an external Pharmacist student in a clinical and medical genetics unit. It was just fascinating. This fascination has guided my research career to date since then. Outside the lab, I enjoy going for long walks in London’s beautiful parks. I also enjoy running and love reading books.

Impact of my work:

Our work deepens our understanding of the consequences of genetic structural variations. This has the potential to make a significant impact. Indeed, this knowledge could lead to the diagnosis of a substantial portion of the 300 million undiagnosed patients with rare diseases and the development of innovative therapeutic strategies for cancer patients.

My Research

Genomic variation and disease

The Genomic Variation and Disease team at the LMS started in 2024. Led by Lila Allou, it aims to understand the molecular consequences of SVs affecting noncoding regions in development and disease, thereby improving rare disease diagnosis and identifying potential therapeutic targets in cancer.

VIEW MY RESEARCH GROUP